Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found ...
But taken together, the requests formed a pattern — one that, in retrospect, traced a regulatory trail that would later reveal unexpectedly high pacemaker battery failure rates, jeopardizing the lives ...
ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...
For years, Boston Scientific's factory tests revealed pacemaker batteries that were failing unexpectedly, according to ...